Our Blog | Biosimilars & Generics | AAM

Interactive Savings Map - Find out how much your state saved from generic and biosimilar medicines.

AAM All Access Podcast

Jul 28, 2022 | Dan Leonard

AAM All Access Podcast: Medicare Drug Price Negotiation is Bad for Patients

AAM Statement on H3

Jul 25, 2022 | Craig Burton

Drug Price Negotiation Proposals Undermine Current Bipartisan Approaches to Lower Drug Spending

AAM All Access Podcast

Jul 21, 2022 | Dan Leonard

AAM All Access Podcast: CMMB’s Urgent Mission

Doesn't Add Up patient photo

Jul 20, 2022 | Craig Burton

The Evidence Is Clear: Biosimilar Competition Will Achieve More Savings for Patients Than Build Back Better’s Negotiations

Senior patient picking up medicines at a pharmacy

Jul 20, 2022 | Craig Burton

Medicare Negotiations Serve as a Catalyst to a Perpetual Monopoly

A pharmacological manufacturing and bottling factory in a bright laboratory environment

Jul 20, 2022 | Craig Burton

Proposed BBB Negotiation Framework Discourages Biosimilar Competition, Imposes Higher Costs on Commercially Insured Patients and Their Employers

Percent of Patients Who Paid the Full Cost of a Generic at Least Once, 2017 and 2020

Jul 12, 2022 | Monét Stanford

Despite Enrollment In Medicare Prescription Drug Coverage, Over Half of All Seniors Pay Full Cost for Many Generic Drugs

AAM All Access Podcast

Jul 1, 2022 | Dan Leonard

AAM All Access Podcast: Drug Shortages and the U.S. Supply Chain

Biosimilars Patient Resource Center

May 31, 2022 | Erica Klinger

Everything You Need to Know About Biosimilars – All in One Place

Ariel with Medicines

May 23, 2022 | Monét Stanford

AAM Calls for Federal Trade Commission to Investigate PBM Business Practices

IQVIA The Use of Medicines in the U.S. 2022 Report

May 2, 2022 | Monét Stanford

Generics Drive Savings Yet Patients Continue to Pay More

Healthcare charts

Apr 19, 2022 | Monét Stanford

As Health Care Spending in US Projected to Increase, Generics and Biosimilars Expected to Moderate Growth